Larvol Delta - SIRPant-Immunotherapeutics-Announces-FDA-Clearance-of-IND-Application-for-SIRPantM-for-the-Treatment-of-Solid-Tumors

SIRPant-M (SI-101) - SIRPant Immunotherap

https://www.globenewswire.com/news-release/2023/12/12/2794702/0/en/SIRPant-Immunotherapeutics-Announces-FDA-Clearance-of-IND-Application-for-SIRPant-MTM-for-the-Treatment-of-Solid-Tumors.html

Dec 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next